Skip to main content
Equibles

QGEN · Qiagen N.V. · Metrics

Track QGEN — free

Use QGEN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research QGEN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$50.86 +0.03 (+0.06%) Play latest call Q2 2026 earnings call transcript
Russell 1000 member Rebalance outlook locked
Market Cap
$10.49B
Shares
206.50M
Volume · Nov 5 4.63M Avg daily vol (3M) 3.71M

QGEN metrics

66 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$50.86
Market cap
$10.49B

Price action

20 metrics
Price change (1W)
+1.0%
Price change (30D)
+11.3%
Price change (3M)
+21.2%
Price change (6M)
+47.6%
Price change (YTD)
+13.0%
Price change (1Y)
+15.1%
Trailing year
Price change (5Y)
-11.5%
52-week high
$55.66
52-week low
$32.63
Change from 52-week high
-8.7%
Change from 52-week low
+55.8%
Annualized volatility
35.6%
Annualized volatility (3M)
32.7%
Beta
0.4
RSI (14D)
74.6
Price vs SMA 50
+11.6%
Price vs SMA 200
+19.3%
Avg volume (3M)
3.67M
Relative volume
0.9
Average dollar volume
$170.90M

Company

3 metrics
Sector
Healthcare
Industry
Diagnostics & Research
Shares outstanding
206.50M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.8
reciprocal yield 36.0%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
5.2%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$2.64
Dividend growth YoY
+956.0%
Dividend growth streak
0
Last ex-dividend
2026-07-07

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-11-04

Profitability

9 metrics
Gross margin
62.2%
Operating margin
22.3%
Trailing 12 months
Net margin
20.3%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$17.42

Growth

11 metrics
Revenue growth YoY
+5.7%
Year over year
Net income growth YoY
+408.3%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+424.3%
Shares change YoY
-2.6%
Year over year · fewer shares
Revenue CAGR (3Y)
-0.8%
Revenue CAGR (5Y)
+2.2%
EPS CAGR (3Y)
+1.8%
EPS CAGR (5Y)
+4.9%
FCF CAGR (3Y)
-8.2%
FCF CAGR (5Y)
+6.9%

Quality

14 metrics
Return on equity
11.2%
Return on assets
6.8%
Debt / equity
0.4
Current ratio
3.9
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
3.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
−$555.51M
Latest balance sheet
Cash & equivalents
$839.00M
Total assets
$6.28B
Total debt
$1.65B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
343
13F filer change QoQ
-12
Institutional ownership
72.3%
Conviction holders (share of 13F filers)
1.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+13.4%
Holder tenure
16.9
Price vs estimated holder cost
-7.2%

Ownership (registered funds)

1 metrics
Index-fund ownership
1.0%

Short interest

3 metrics
Short interest
3.5%
Latest settlement · 3.3 days to cover
Days to cover
3.3d
Short-squeeze score
64 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1015820 CUSIP N72482156 13F (30d) 132 filings 113 filers Visit website Investor relations